Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
about
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasiaPhosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive reviewUdenafil for the treatment of erectile dysfunctionLower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment.Testosterone Deficiency and Nocturia: A Review.A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunctionImpact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile functionMirodenafil prevents bladder dysfunction induced by chronic bladder ischemia in rats.Late-onset hypogonadism syndrome and lower urinary tract symptoms.Lower urinary tract disease: what are we trying to treat and in whom?Correlation between lower urinary tract symptoms and premature ejaculation in Korean men older than 40 years old [corrected]The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.Long-Term Effects of a Randomised Controlled Trial Comparing High Protein or High Carbohydrate Weight Loss Diets on Testosterone, SHBG, Erectile and Urinary Function in Overweight and Obese Men.Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses.Sleep disturbances and sexual function among men aged 45-75 years in an urban area of Iran.A survey of commonalities relevant to function and dysfunction in pelvic and sexual organs.Discovering medical conditions associated with periodontitis using linked electronic health records.Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence.Association between metabolic syndrome and sexual dysfunction among men with clinically diagnosed diabetes.Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis.Nocturia and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo StudyUrinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.Measurement of benign prostatic hyperplasia treatment effects on male sexual function.Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical management.Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.Benign prostate hyperplasia and stem cells: a new therapeutic opportunity.Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.Tadalafil - a therapeutic option in the management of BPH-LUTS.Tadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in Russia.Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms.Testosterone Replacement Therapy on the Natural History of Prostate Disease.Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up.Impact of Monopolar TURP, Bipolar TURP and Photoselective Vaporization of Prostate for Enlarged Prostate on Erectile Function.The effect of alpha-blocker therapy on erectile functions in patients with lower urinary tract symptoms due to benign prostate hyperplasia.Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: Results of a regional population-based survey and comparison with industrialized nations.Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms.Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract.Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late-Onset Hypogonadism Syndrome.
P2860
Q24199135-3A1C6E9D-8BA4-40ED-A670-EAE6EF9E7779Q26785752-9E512F3B-A617-4872-AE5E-B6A7EFDE14D8Q26851999-0672035C-2149-4EC4-A2FD-FFC3C385AD96Q33289952-E28770E7-A8C6-4932-914E-0054DA2FC68BQ33642001-4E53724A-231B-4EA1-AD34-192C9BF5E7A9Q33744285-4C9A27D9-AE4B-43A2-B074-996D576C058DQ34567905-B3282113-AAE2-41EA-889F-8E32EB12C83FQ35281132-FAF2505A-F38E-4D58-9778-D18E9893A3E5Q35539874-C2608F18-C1D0-4D9D-9DF6-4A6250903C30Q35545715-371D740B-3D44-42CB-A013-064C0183480EQ35852000-9D44ED98-EDA6-49B9-A8AB-E6144C4E1F37Q36054510-5855F370-76A0-4C08-A900-0B2B86EBB96EQ36119993-9DD11F4C-C6EB-462F-A117-2487621242DAQ36409135-F8E4860C-F0A3-46F0-B6ED-32AD315D68EFQ36676598-89548102-8185-4952-B91C-BAAE9F313F4BQ36901153-63AA6575-637F-4292-B09A-4A86C511222BQ36918641-F74B8E29-84DF-461A-AA65-172041529B6AQ36948833-8917B759-CE05-48A1-B372-2956F93A5AB7Q37018954-5F6F619F-32F8-42B7-81F6-19CAE7F7A147Q37070710-E7C45A05-23E0-483F-8A4F-CB990F52BB05Q37108885-225D2AF0-45F3-4442-89FF-FEAE827C4BBDQ37227429-E5A073A3-0859-447A-A1A2-5A01704DD205Q37466573-E2CD0F65-0DC2-42F7-BEA2-C62FC7C12EB6Q37523227-F481C76E-4A48-4617-B9CB-03AE8C88CBC4Q37719924-6BD301DE-897C-4BB3-AFED-464FA6514BFAQ37877132-5FFC3180-D462-4C21-86E3-A0D5C377E183Q37896170-1DB42BAC-6228-45F2-94E1-ED560C8D01EDQ38052058-922E84F2-FFCF-4529-909D-2A224F2EBCD0Q38063330-E9C1F46E-D5B4-43C1-9640-F4CCBE23E746Q38171532-827C1EC5-B4C8-4BC6-9E6D-3EC28DE8F646Q38241547-53C5EEC7-A13C-4756-8F6D-12E051CEF1A5Q38262087-0079FA9F-81A4-41C9-9162-64969980F49EQ38528388-274E2B5F-440E-4B5B-A216-C951F7C98131Q38621379-49D55F13-A62D-41C4-95C2-83C64D541234Q38649693-F52F371F-077D-45C9-BD46-43695ABF996FQ39297278-4BC3F18D-5890-4E3E-9C2A-100BBF0D5F83Q39771272-A80F5FEB-4987-47D5-B504-AA12A8A7891DQ39820249-EF7ADB8B-DF1D-41EC-AD32-CD1B9090F51CQ40094464-96EE0F9E-DF48-4979-97F0-4E6565683CC1Q40215525-7CE18A62-29D5-474D-8B9F-08C334342B06
P2860
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
@ast
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
@en
type
label
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
@ast
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
@en
prefLabel
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
@ast
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
@en
P1433
P1476
Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
@en
P2093
Kevin T McVary
P304
P356
10.1016/J.EURURO.2005.02.001
P407
P577
2005-02-22T00:00:00Z